Company profile
Apex Molecular Limited
Home - Apex MolecularApex Molecular
We are a leading provider of specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors. Apex offers FFS and FTE contracts for bespoke custom synthesis and medicinal chemistry projects %
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Small
Accounts AnalysedAA | Transaction MzQzODU0OTg1N2FkaXF6a2N4
Published 07 Oct 2024 07:41
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
Apex Molecular operates a laboratory and undertakes contracted synthetic chemistry jobs for clients in the pharmaceutical, biotechnology and applied chemical sectors.
SIC 20037310 - Research And Experimental Development On Natural Sciences And Engineering SIC 200772110 - Research And Experimental Development On Biotechnology Keywords biotechnology research & development natural science research & development research & development engineering research & development chemical substance development chemistry process technology scales pharmaceutical research hydrogenation customs
Project impact
Development of immobilised catalysts
Public funding
Projects
Manufacture of chiral amines using catalytic and flow processing methods
1 Feb 2013 to 31 Jan 2015
Chiral amines are important building blocks used in 40% pharmaceutical products, 20% of crop protection compounds and are high value chemical intermediates. Current synthetic methods use wasteful resolution processes. This project will improve manufacturing efficiency by developing catalytic (transfer) hydrogenation methods to make specific types of chira...
CP-STAR - Tethered catylysts: Step-change high purity manufacture of high value pharmaceutical fine chemical and biotechnology products
1 Oct 2009 to 31 May 2013
This industry-led project will enable new approaches to process chemistry based on advances in synthetic methods. The project investigates 'tethering' of new catalyst ligands to solid supports (such as polymer beads or porous surfaces) to prevent catalyst and reagent residues ending up in products and allow re-use and recycling. This also enables new, int...